HDR Mould-Based Brachytherapy for Cutaneous Neoplasms: Toxicity, Long-Term Control, Cosmesis and PROMs
High-dose-rate MbBT for CN is an effective and well-tolerated treatment option for older and frail patients who are not eligible for radical surgery or definitive EBRT.
Authors
- Christian Scherf (ORCID: https://orcid.org/0000-0003-0520-8970)
- Bastian Schilling (ORCID: https://orcid.org/0000-0001-8859-4103)
- Claus Rödel
- Georgios Chatzikonstantinou
- Ulla Ramm
- Johannes Kleemann (ORCID: https://orcid.org/0000-0002-2005-5282)
- Nikolaos Tselis (ORCID: https://orcid.org/0009-0004-7800-6127)
- Janosch Achenbach (ORCID: https://orcid.org/0000-0001-9712-1471)
- Markus Diefenhardt (ORCID: https://orcid.org/0000-0002-9042-9729)
- Jörg Licher (ORCID: https://orcid.org/0000-0002-2948-1181)
- Kim Nikola Zeiner
Institutions
- Goethe University Frankfurt (DE)
- Luzerner Kantonsspital (CH)
- University Hospital Frankfurt (DE)
- Frankfurt Cancer Institute (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1007/s13555-025-01577-x
- Citations
- 1
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35